BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33371777)

  • 1. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
    Chen S; Wei Y; Liu H; Gong Y; Zhou Y; Yang H; Tang L
    Bioengineered; 2021 Dec; 12(1):127-137. PubMed ID: 33371777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
    Zhu C; Xiao D
    Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
    Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
    Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.
    Liu Q; Zhao H; Guo Y; Zhang K; Shang F; Liu T
    J Healthc Eng; 2022; 2022():7904982. PubMed ID: 36105715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 8. TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.
    Li T; Huang H; Shi G; Zhao L; Li T; Zhang Z; Liu R; Hu Y; Liu H; Yu J; Li G
    Cell Death Dis; 2018 Aug; 9(9):849. PubMed ID: 30154451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients.
    Necula L; Matei L; Dragu D; Pitica I; Neagu AI; Bleotu C; Dima S; Popescu I; Diaconu CC; Chivu-Economescu M
    World J Gastroenterol; 2020 Jun; 26(22):3024-3033. PubMed ID: 32587446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis.
    Zhao Y; Hu S; Zhang J; Cai Z; Wang S; Liu M; Dai J; Gao Y
    Bioengineered; 2021 Dec; 12(1):5641-5654. PubMed ID: 34506251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
    Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
    Front Immunol; 2023; 14():955949. PubMed ID: 37006317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
    Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
    J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
    Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
    Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hou W; Kong L; Hou Z; Ji H
    BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
    Li J; Su T; Yang L; Zhang C; He Y
    Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
    Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
    Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High COL10A1 expression potentially contributes to poor outcomes in gastric cancer with the help of LEF1 and Wnt2.
    Zhang M; Jin M; Gao Z; Yu W; Zhang W
    J Clin Lab Anal; 2022 Sep; 36(9):e24612. PubMed ID: 35929139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.